Ras-dependent carbon metabolism and transformation in mouse fibroblasts

Mutational activation of ras genes is required for the onset and maintenance of different malignancies. Here we show, using a combination of molecular physiology, nutritional perturbations and transcriptional profiling, that full penetrance of phenotypes related to oncogenic Ras activation, including the shift of carbon metabolism towards fermentation and upregulation of key cell cycle regulators, is dependent upon glucose availability. These responses are induced by Ras activation, being specifically reverted by downregulation of the Ras pathway obtained through the expression of a dominant-negative Ras-specific guanine nucleotide exchange protein. Our data allow to link directly to ras activation the alteration in energy metabolism of cancer cells, their fragility towards glucose shortage and ensuing apoptotic death.

[1]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[2]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[3]  M. Perucho,et al.  Activation of a human c-K-ras oncogene. , 1984, Nucleic acids research.

[4]  M. Barbacid,et al.  ras gene Amplification and malignant transformation , 1985, Molecular and cellular biology.

[5]  E. Newsholme,et al.  Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. , 1990, The Biochemical journal.

[6]  L. Baggetto,et al.  Deviant energetic metabolism of glycolytic cancer cells. , 1992, Biochimie.

[7]  Z. Darżynkiewicz,et al.  Features of apoptotic cells measured by flow cytometry. , 1992, Cytometry.

[8]  D. Lowy,et al.  Function and regulation of ras. , 1993, Annual review of biochemistry.

[9]  L. Feig,et al.  Guanine-nucleotide exchange factors: a family of positive regulators of Ras and related GTPases. , 1994, Current opinion in cell biology.

[10]  C. Albanese,et al.  Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.

[11]  J. Bos.  p21ras: an oncoprotein functioning in growth factor-induced signal transduction. , 1995, European journal of cancer.

[12]  F. Bosman,et al.  p21ras in carcinogenesis. , 1996, Pathology, research and practice.

[13]  Saroj P. Mathupala,et al.  Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-translational, and Mutational Events That Lead to a Critical Role for Type II Hexokinase , 1997, Journal of bioenergetics and biomembranes.

[14]  S. Moreno,et al.  Regulation of CDK/cyclin complexes during the cell cycle. , 1997, The international journal of biochemistry & cell biology.

[15]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[16]  Chinfei Chen,et al.  Heat Shock Factor 1 Represses Ras-induced Transcriptional Activation of the c-fos Gene* , 1997, The Journal of Biological Chemistry.

[17]  D. Spitz,et al.  Glucose Deprivation-induced Cytotoxicity and Alterations in Mitogen-activated Protein Kinase Activation Are Mediated by Oxidative Stress in Multidrug-resistant Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[18]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[19]  N. Dyson.  The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[20]  U. Rapp,et al.  Cell cycle targets of Ras/Raf signalling , 1998, Oncogene.

[21]  D. Fell,et al.  A control analysis exploration of the role of ATP utilisation in glycolytic-flux control and glycolytic-metabolite-concentration regulation. , 1998, European journal of biochemistry.

[22]  Xiao-Fan Wang,et al.  Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites , 1999, Oncogene.

[23]  G. Semenza,et al.  Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.

[24]  S. Jinno,et al.  Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Martínez-A,et al.  Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: Implications in prevention of apoptosis , 1999, Oncogene.

[26]  L. Alberghina,et al.  Characterization and Properties of Dominant-negative Mutants of the Ras-specific Guanine Nucleotide Exchange Factor CDC25Mm * , 1999, The Journal of Biological Chemistry.

[27]  P. Steinberg,et al.  Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells , 1999, Journal of cellular physiology.

[28]  O. Cochet,et al.  Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy? , 1999, Cancer detection and prevention.

[29]  A. Watanabe,et al.  Growth inhibition of human pancreatic cancer cell lines by anti‐sense oligonucleotides specific to mutated K‐ras genes , 1999, International journal of cancer.

[30]  James M. Roberts,et al.  The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts , 1999, The EMBO journal.

[31]  Y. Lee,et al.  Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. , 1999, Free radical biology & medicine.

[32]  C. Der,et al.  The Ras branch of small GTPases: Ras family members don't fall far from the tree. , 2000, Current opinion in cell biology.

[33]  L. Ridnour,et al.  Glucose Deprivation‐Induced Oxidative Stress in Human Tumor Cells: A Fundamental Defect in Metabolism? , 2000, Annals of the New York Academy of Sciences.

[34]  L. Alberghina,et al.  A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts , 2000, Oncogene.

[35]  M. V. Heiden,et al.  Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Takeda,et al.  ASC1/RAS2 Suppresses the Growth Defect on Glycerol Caused by the atp1–2 Mutation in the YeastSaccharomyces cerevisiae * , 2000, The Journal of Biological Chemistry.

[37]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[38]  C. Dang,et al.  Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.

[39]  R. Assoian,et al.  Integrating the MAP kinase signal into the G1 phase cell cycle machinery. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[40]  H. Katoh,et al.  The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice , 2000, Gene Therapy.

[41]  J. McCubrey,et al.  P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells , 2001, Oncogene.

[42]  Y. Takuwa,et al.  Regulation of cell cycle molecules by the Ras effector system , 2001, Molecular and Cellular Endocrinology.

[43]  Carlos L. Arteaga,et al.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization , 2002, Nature Medicine.

[44]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[45]  Jie Zhang,et al.  Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Bernards,et al.  Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.

[47]  J. Slingerland,et al.  PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest , 2002, Nature Medicine.

[48]  Alfonso Bellacosa,et al.  Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer , 2002, Nature Medicine.

[49]  H. Aguilaniu,et al.  The oncogenicRAS2val19 mutation locks respiration, independently of PKA, in a mode prone to generate ROS , 2003, The EMBO journal.

[50]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[51]  Floral Radiography: Using X rays to Create Fine Art 1 , 2003 .

[52]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[53]  K. Helin,et al.  E2F target genes: unraveling the biology. , 2004, Trends in biochemical sciences.

[54]  T. Nheu,et al.  PAK Is Essential for RAS-Induced Upregulation of Cyclin D1 During the G1 to S Transition , 2004, Cell cycle.

[55]  H. Kitano.  Cancer as a robust system: implications for anticancer therapy , 2004, Nature Reviews Cancer.

[56]  Lilia Alberghina,et al.  Systems Biology and the Molecular Circuits of Cancer , 2004, Chembiochem : a European journal of chemical biology.

[57]  F. O’Sullivan,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.

[58]  W. Willis,et al.  Pyruvate and citric acid cycle carbon requirements in isolated skeletal muscle mitochondria. , 2004, American journal of physiology. Cell physiology.

[59]  Kyu-Won Kim,et al.  Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions , 2004, Experimental & Molecular Medicine.

[60]  S. Flanagan,et al.  Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. , 2005, The Journal of biological chemistry.

[61]  S. Schreiber,et al.  Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. Gillies,et al.  Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors , 2005 .

[63]  Subcellular distribution of Ras GTPase isoforms in normal human kidney. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[64]  F. Chiaradonna,et al.  Acquired glucose sensitivity of k-ras transformed fibroblasts. , 2005, Biochemical Society transactions.

[65]  V. Shoshan-Barmatz,et al.  The voltage-dependent anion channel , 2007, Cell Biochemistry and Biophysics.